http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1164204_PMID25221653

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103174500_AID1164204_PMID25221653_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312357787_AID1164204_PMID25221653_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312357786_AID1164204_PMID25221653_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312357664_AID1164204_PMID25221653_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103191369_AID1164204_PMID25221653_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103764925_AID1164204_PMID25221653_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312357788_AID1164204_PMID25221653_VALUE9
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID160708712_AID1164204_PMID25221653_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103179087_AID1164204_PMID25221653_VALUE2
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35354
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Inhibition of human recombinant COX2 at saturation drug level pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160708712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312357664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103764925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103191369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103174500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312357788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312357786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103179087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312357787
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1164204

Total number of triples: 23.